Lead and Impact: Turning Innovation into Practice
Pairing for Prevention
Highlight next-generation immuno-oncology treatments under development, and the issues in clinical trial designs and disease-quantification (e.g., irRECIST) pertaining to these new approaches.
Molecular Targets and Cancer Therapeutics
Where Science Meets Technology Meets the Future
Best practices and cutting-edge examples of how life sciences companies can more fully incorporate the patient voice into the work they do.
Research on lysosomal diseases
Postponed until 2021